| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Richard A Anderson | |
| Adam H Balen | |||
| Policy & Practice Committee of the BFS | |||
| P2860 | cites work | Metformin in polycystic ovary syndrome: systematic review and meta-analysis | Q22242098 |
| Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial | Q22242102 | ||
| Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome | Q22250886 | ||
| Should obese women with polycystic ovary syndrome receive treatment for infertility? | Q24541340 | ||
| Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study | Q28194701 | ||
| Fat and female fecundity: prospective study of effect of body fat distribution on conception rates | Q28266908 | ||
| Weight loss and menstrual cycle: clinical and endocrinological evaluation | Q47415490 | ||
| Obesity and the risk of spontaneous abortion after oocyte donation | Q48829108 | ||
| Impact of overweight and underweight on assisted reproduction treatment. | Q50671968 | ||
| The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. | Q50891475 | ||
| Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage. | Q51554599 | ||
| The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. | Q51558611 | ||
| Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. | Q51561976 | ||
| Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. | Q51563371 | ||
| Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. | Q52039249 | ||
| Leptin and leptin binding activity in the preovulatory follicle of polycystic ovary syndrome patients. | Q54018676 | ||
| Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin | Q56391115 | ||
| Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization | Q58323756 | ||
| Increased body mass index has a deleterious effect on in vitro fertilization outcome | Q30460480 | ||
| Body mass index and metabolic risk factors for coronary heart disease in women | Q31759767 | ||
| Treatment of obesity: need to focus on high risk abdominally obese patients | Q33804631 | ||
| Obesity is a risk factor for early pregnancy loss after IVF or ICSI. | Q33887602 | ||
| Anthropometric indicators and response to gonadotrophin for ovulation induction | Q34328600 | ||
| Effects of weight loss on the hormonal profile in obese, infertile women | Q34407556 | ||
| An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer | Q34445650 | ||
| Polycystic ovary syndrome and fat distribution: the central issue? | Q34704670 | ||
| What is polycystic ovary syndrome? Are national views important? | Q34803214 | ||
| A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome | Q35043730 | ||
| ABC of obesity. Obesity and reproduction | Q35185709 | ||
| Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis | Q35593821 | ||
| Improving reproductive performance in overweight/obese women with effective weight management | Q35772125 | ||
| Effects of obesity on women's reproduction and complications during pregnancy | Q35831667 | ||
| Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation | Q36160138 | ||
| Does body mass index of infertile women have an impact on IVF procedure and outcome? | Q36270481 | ||
| Nutrition and reproduction in women | Q36383128 | ||
| Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system | Q36499490 | ||
| Obesity and the role of gut and adipose hormones in female reproduction | Q36507088 | ||
| Effect of overweight and obesity on assisted reproductive technology--a systematic review | Q36856192 | ||
| Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study | Q37366366 | ||
| New concepts in human sperm-zona pellucida interaction | Q38290761 | ||
| Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study | Q39593199 | ||
| Baseline non-fasting serum leptin concentration to body mass index ratio is predictive of IVF outcomes | Q40689078 | ||
| Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. | Q42457294 | ||
| Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome | Q42519095 | ||
| The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome | Q43626625 | ||
| Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. | Q43723378 | ||
| Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? | Q44118719 | ||
| Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss | Q44127878 | ||
| IVF outcome in anovulatory infertility (WHO group 2)--including polycystic ovary syndrome--following previous unsuccessful ovulation induction | Q44557473 | ||
| The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome | Q44573417 | ||
| Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study | Q44822507 | ||
| High prepregnancy body-mass index--a maternal-fetal risk factor | Q46358662 | ||
| Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study | Q46731864 | ||
| Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss | Q47175364 | ||
| Effect of female body weight on efficiency of donor AI. | Q47177687 | ||
| Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment | Q47284099 | ||
| Fetal and embryonic hemoglobins in erythroblasts from fetal blood and fetal cells enriched from maternal blood in pregnancies complicated by maternal diabetes mellitus | Q47314291 | ||
| Effects of subfertility cause, smoking and body weight on the success rate of IVF. | Q47385887 | ||
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 195-206 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Human Fertility | Q5937141 |
| P1476 | title | Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines | |
| P478 | volume | 10 |
| Q48008143 | A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors |
| Q90264298 | Association between parental anthropometric measures and the outcomes of intracytoplasmic sperm injection cycles |
| Q28069737 | Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility |
| Q28383191 | Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS |
| Q54302144 | Body mass index and central adiposity are associated with sperm quality in men of subfertile couples. |
| Q48261115 | Chronic hyperandrogenemia and western-style diet beginning at puberty reduces fertility and increases metabolic dysfunction during pregnancy in young adult, female macaques. |
| Q46538155 | Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial. |
| Q37965116 | Complications and outcome of assisted reproduction technologies in overweight and obese women |
| Q30245233 | Drivers of maternity care in high-income countries: can health systems support woman-centred care? |
| Q35017475 | Effect of overweight/obesity on IVF-ET outcomes in chinese patients with polycystic ovary syndrome |
| Q39231780 | Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT. |
| Q34312544 | Effects of metformin use in pregnant patients with polycystic ovary syndrome |
| Q38007201 | Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology |
| Q36048415 | Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome |
| Q43778098 | Infertility treatment in a population-based sample: 2004-2005. |
| Q37218949 | Infertility treatment outcome in sub groups of obese population |
| Q35496158 | Intergenerational cycle of obesity and diabetes: how can we reduce the burdens of these conditions on the health of future generations? |
| Q55291215 | Interpregnancy weight change and adverse pregnancy outcomes: a systematic review and meta-analysis. |
| Q42365800 | Lifestyle Intervention for Obese Women. |
| Q35208528 | Long-term hyperphagia and caloric restriction caused by low- or high-density husbandry have differential effects on zebrafish postembryonic development, somatic growth, fat accumulation and reproduction |
| Q36970417 | Low grade inflammation, as evidenced by basal high sensitivity CRP, is not correlated to outcome measures in IVF. |
| Q34754686 | Maternal obesity and occurrence of fetal macrosomia: a systematic review and meta-analysis. |
| Q64986206 | Metformin in Pregnancy: Mechanisms and Clinical Applications. |
| Q22242884 | Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications |
| Q37103661 | Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome |
| Q27023149 | Obesity and reproductive function |
| Q89143007 | Optimizing reproductive health in women with obesity and infertility |
| Q47392125 | Prevalence of body mass index and body weight cut-off points for in vitro fertilization treatment at U.S. clinics and current clinic weight loss strategy recommendations |
| Q44771862 | Recent insights into the influence of female bodyweight on assisted reproductive technology outcomes |
| Q64896865 | The Effects of Overweight and Obesity on Assisted Reproduction Technology Outcomes. |
| Q46895355 | The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: "Think Nutrition First". |
| Q33616835 | The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial |
| Q35860762 | The Obesity-Fertility Protocol: a randomized controlled trial assessing clinical outcomes and costs of a transferable interdisciplinary lifestyle intervention, before and during pregnancy, in obese infertile women |
| Q38442527 | The effects of morbid obesity on maternal and neonatal health outcomes: a systematic review and meta-analyses |
| Q34157761 | The impact of female obesity on the outcome of fertility treatment |
| Q51115962 | The impact of maternal body mass index on in vitro fertilization outcomes. |
| Q37942617 | The impact of raised BMI on the outcome of assisted reproduction: current concepts |
| Q88886716 | The influence of body mass index on pregnancy outcome following single-embryo transfer |
| Q38924361 | The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance |
| Q37781055 | The role of bariatric surgery in the management of female fertility |
| Q36930736 | Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India |
Search more.